Navigation Links
AstraZeneca Announces Top-line Phase III Results from Naloxegol Pivotal Trials In Patients With Opioid-Induced Constipation
Date:11/12/2012

sis. All three trials were conducted in patients with non-cancer pain and documented OIC, who require daily opioid therapy.

Enrolment is complete for the open-label, randomized, 52-week long-term safety trial (KODIAC-08) and the trial is expected to be completed by Q1 2013.

Naloxegol is currently considered a Schedule II controlled substance by the US Drug Enforcement Administration (DEA) based on structural relatedness to noroxymorphone. AstraZeneca has conducted the studies necessary to evaluate the abuse potential and dependence-producing properties of naloxegol in support of obtaining decontrol. A petition for the decontrol of naloxegol was submitted to the DEA in March 2012 and subsequently accepted for review. Commercialisation and launch in the US will be subject to both FDA approval and DEA schedule determination.

Nektar to Host Conference Call with Investors and AnalystsNektar Therapeutics (Nasdaq: NKTR) will host an investor and analyst conference call today to discuss these results.  The call will begin at 8:15 a.m. Eastern Standard Time (EST)/5:15 a.m. Pacific Standard Time (PST).
A link to the live conference call webcast is accessible from the home page of the Nektar website: http://www.nektar.com.

To access the conference call live by telephone, please follow these instructions:

Dial: (877) 881-2183 (U.S.); (970) 315-0453 (international)
Passcode: 70465377 (Nektar Therapeutics is the host)

About Naloxegol
Naloxegol is a peripherally-acting mu-opioid receptor antagonist being investigated for the treatment of constipation (opioid-induced constipation or OIC) as a side effect of prescription opioid pain medicines.

Top-line results of the Phase II study of naloxegol (formerly NKTR-118) were previously presented at the American College of Gastroenterology Annual Clinical
'/>"/>

SOURCE Nektar Therapeutics
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Palatin Technologies Provides Update Regarding Its Obesity Research/Development Collaboration with AstraZeneca
2. Palatin Technologies Announces Halting of Phase I Clinical Trial of Obesity Compound in AstraZeneca Research Collaboration
3. AstraZeneca and Rigel Sign Worldwide License Agreement for a Potential New Treatment for Chronic Asthma
4. Covington Advises AstraZeneca in $1.26 Billion Acquisition of Ardea Biosciences
5. China Cord Blood Corporation Announces Completion of Strategic Partnership with Cordlife Group Limited
6. Apexigen Announces Initiation of Clinical Trials By Its Partner, Simcere Pharmaceutical Group
7. Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2012 Financial Results
8. Boston Childrens Hospital announces international genomics competition winner
9. Sangamo BioSciences Announces Presentation At The Lazard Capital Markets Healthcare Conference
10. OncoGenex Announces Completion Of Patient Enrollment In Custirsen Phase 3 "SYNERGY" Study
11. AMRI Announces Third Quarter 2012 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2013)... In late 2012, Dr. Sarah Hart, of ... in China about Appearance Medicine . Although Dr. Hart ... first trip to lecture in China, and quite a different ... home to 12 and 7 million people respectively. Interest in ... this point in time. As Dr. Hart passed through the ...
(Date:5/16/2013)... 2013  HealthSparq, a trusted provider of healthcare ... regional health plans, will debut a new benchmark ... Institute 2013 conference on June 13.  The presentation ... health insurance companies across the country are thinking ... demands for increased healthcare transparency. ...
(Date:5/16/2013)... On average, developing a new drug ... dollars. Despite this investment, less than 10% of drugs ... your clinical trial design optimally structured to balance time, ... Dr. Frederic Sax, Global Head of the Center for ... data, information and technology in upfront clinical trial planning ...
(Date:5/16/2013)... DNA Genotek, a leading provider of products for biological sample ... conjunction with the African Society of Human Genetics (AfSHG). Spit ... cost of DNA collection for locally and internationally ... in Africa (H3 Africa) Initiative and to facilitate growth in ... AfSHG is to build the capacity of African researchers ...
Breaking Biology Technology:HealthSparq to Reveal New Healthcare Transparency Benchmark Study at AHIP Institute 2013 2HealthSparq to Reveal New Healthcare Transparency Benchmark Study at AHIP Institute 2013 3Optimizing Clinical Trials Outcomes through Computer Assisted Design, New Life Science Webinar Hosted by Xtalks 2DNA Genotek Inc. Announces Spit for Africa Program 2DNA Genotek Inc. Announces Spit for Africa Program 3
... (Amex: BUF ) announced today that the Company will ... results,on Tuesday, May 13, 2008 at 4:30 PM ET. The ... on Tuesday, May 13, 2008., The toll free call ... call in number is (404) 260-1421., Contact: ...
... the world,s leading,online bioscience job board and ... the 2008 Bio NC(TM) Hotbed Campaign for ... http://www.newscom.com/cgi-bin/prnh/20080508/CLTH087 ), (Logo: ... highlights the biotechnology, pharmaceutical and,medical device communities ...
... May 8 Applied Isotope Technologies ("AIT"),announced today ... used for the analyses of samples from autistic ... in an,Environmental Pediatric Room to be constructed at ... a specialist in Autism Spectrum,Disorders (ASD) will lead ...
Cached Biology Technology:MINRAD International, Inc. to Discuss 2008 First Quarter Financial Results on Tuesday, May 13, 2008 2BioSpace Launches 6th Edition of Bio NC(TM) Hotbed Campaign 2Applied Isotope Technologies will Exclusively Supply Biochemimarker(TM) Discovery Products for a Unique Pilot Study on Autism 2
(Date:5/16/2013)... of genome-wide analysis (GWA), where the entirety of an ... mutations or variants which can cause health problems is ... it can also pose major ethical problems if used ... Human Genetics (ESHG) published on line today (16 May ... ., Many services based on whole genome and on ...
(Date:5/16/2013)... a conservationist working in Cameroon and the manager of ... been awarded the prestigious Whitley award. The Whitley ... "The Green Oscars" because it celebrates the extraordinary achievements ... developing countries. Abwe was selected for the award ... Cameroon,s Ebo Forest and its wildlife inhabitants., HRH The ...
(Date:5/16/2013)... , May 16, 2013 ... report is available in its catalogue: ... & Opportunities, 2018 http://www.reportlinker.com/p01181929/Global-Biometric-Systems-Market-Forecast--Opportunities-2018.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Security_Systems ... and old security practises such as photographs, ... growth of biometric technologies in last few ...
Breaking Biology News(10 mins):European Society of Human Genetics urges caution over use of new genetic sequencing techniques 2Cameroon researcher wins prestigious 'Green Oscar' 2Cameroon researcher wins prestigious 'Green Oscar' 3Global Biometric Systems Market Forecast & Opportunities, 2018 2Global Biometric Systems Market Forecast & Opportunities, 2018 3Global Biometric Systems Market Forecast & Opportunities, 2018 4Global Biometric Systems Market Forecast & Opportunities, 2018 5Global Biometric Systems Market Forecast & Opportunities, 2018 6Global Biometric Systems Market Forecast & Opportunities, 2018 7
... selection at the single-gene level have a powerful new ... in molecular and computational biology in the USC College ... sought to replace the standard neutral model, a common ... method based on hard genomic data. , The group's ...
... cause a range of diseases in several animal species has ... to it, was found most often in the blood of ... to blood exposure. , A study on these findings was ... Medical Virology, by scientists from Oregon State University, the Center ...
... A recent mandate to screen blood donations in all US states ... health point of view, say researchers from Columbia University and Harvard ... yet the time of year to worry about mosquitoes, it seems ... on screening blood products for WNV, and to ensure that the ...
Cached Biology News:Natural selection at single gene demonstrated 2Ocean virus identified in human blood samples 2Ocean virus identified in human blood samples 3Ocean virus identified in human blood samples 4Screening blood for West Nile virus 2
Human Jagged 2 Biotinylated Affinity Purified PAb...
Griess Reagent component for determination of nitrite in aqueous solutions....
... The SYBR Safe photographic filter ... Gels and Blots) is ideal for ... the SYBR Safe DNA gel stain, ... that the SYBR Safe photographic filter ...
Enodgenous alkaline phosphotase inhibitor. Levamisole solution is supplied in concentrated form (20x). The final concentration of levamisole in the substrate solution will be 1 mM....
Biology Products: